002788SZSE

2026 First Quarter Report

Luyan Pharmaceutical Co., Ltd.··12p

✨ AI Summary

This report details the company's financial performance for the first quarter of 2026. Operating revenue increased by 3.43% to 5,351,016,756.02 yuan. However, net profit significantly decreased to -249,967,562.51 yuan, a 207.35% drop from the previous year. The company's audit committee has reviewed the report, which highlights these material changes in financial results.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openaiSign In to Upgrade

Important Content Reminder:

  1. The company and its management are responsible for the authenticity, accuracy, and completeness of the information disclosed in this report, and there are no false records, misleading statements, or major omissions.

  2. The company’s main responsible persons and the accounting personnel (accounting personnel) confirm that the information in this report is true, accurate, and complete.

  3. The first quarter report has been reviewed by the audit committee.

ItemCurrent PeriodSame Period Last YearChange (%)
Operating Revenue (yuan)5,351,016,756.025,173,756,306.593.43
Profit from Listed Company’s Shareholding (yuan)67,936,460.0271,323,645.12-4.75
Profit from Listed Company’s Non-Operating Shareholding (yuan)66,633,844.8670,886,100.17-6.00
Net Profit (yuan)-249,967,562.51-81,329,060.26-207.35
Basic Earnings per Share (yuan/share)0.170.18-5.56
Average Return on Equity (%)2.032.23-0.20

Non-Operating Loss Items and Amounts

ItemCurrent Period AmountDescription
Non-Operating Loss-687,068.86
Calculation of Non-Operating Loss (with company’s financial statements)2,680,974.09
Loss from Other Items-50,844.83
Total Tax Payable525,849.96
Less: Deferred Tax Assets114,595.28
Other Items1,302,615.16

Stock Information

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…